Apollo Hospitals Enterprise (BOM:508869) Cyclically Adjusted Revenue per Share: ₹1,318.20 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:508869 Apollo Hospitals Enterprise Ltd BOM:508869
94 GF Score
Price ₹8,790.00
GF Value ₹9,113.82
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Apollo Hospitals Enterprise Cyclically Adjusted Revenue per Share?

Apollo Hospitals Enterprise BOM:508869 -0.99% 94 Cyclically Adjusted Revenue per Share is ₹1,318.20 as of Jun. 2026. GuruFocus rates BOM:508869 with a GF Score™ of 94/100 and a GF Value™ of ₹9,113.82 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Apollo Hospitals Enterprise's adjusted revenue per share for the three months ended in Jun. 2026 was ₹489.662. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹1,318.20 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Apollo Hospitals Enterprise's average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-27), Apollo Hospitals Enterprise's current stock price is ₹8790.00. Apollo Hospitals Enterprise's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹1,318.20. Apollo Hospitals Enterprise's Cyclically Adjusted PS Ratio of today is 6.67.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Apollo Hospitals Enterprise was 6.85. The lowest was 5.24. And the median was 6.10.


Apollo Hospitals Enterprise  (BOM:508869) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Apollo Hospitals Enterprise's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=8790.00/1318.20
=6.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Apollo Hospitals Enterprise was 6.85. The lowest was 5.24. And the median was 6.10.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Apollo Hospitals Enterprise Cyclically Adjusted Revenue per Share Related Terms


Apollo Hospitals Enterprise Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Apollo Hospitals Enterprise's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollo Hospitals Enterprise Cyclically Adjusted Revenue per Share Chart

Apollo Hospitals Enterprise Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1,153.70 1,274.89

Apollo Hospitals Enterprise Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,184.62 1,221.90 1,247.61 1,274.89 1,318.20

BOM:508869 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apollo Hospitals Enterprise Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Apollo Hospitals Enterprise's Cyclically Adjusted PS Ratio falls into.


BOM:508869
94GF Score
Apollo Hospitals Enterprise Ltd BOM:508869
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apollo Hospitals Enterprise Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Apollo Hospitals Enterprise's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=489.662/167.3573*167.3573
=489.662

Current CPI (Jun. 2026) = 167.3573.

Apollo Hospitals Enterprise Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 158.915 111.317 238.919
201809 173.484 115.142 252.157
201812 179.311 115.142 260.626
201903 177.936 118.202 251.932
201906 184.798 120.880 255.852
201909 204.227 123.175 277.482
201912 209.201 126.235 277.350
202003 202.962 124.705 272.380
202006 156.143 127.000 205.761
202009 198.339 130.118 255.103
202012 198.478 130.889 253.778
202103 193.386 131.771 245.613
202106 261.527 134.084 326.425
202109 258.584 135.847 318.564
202112 253.037 138.161 306.510
202203 237.830 138.822 286.717
202206 263.849 142.347 310.206
202209 295.702 144.661 342.095
202212 296.369 145.763 340.276
202303 287.683 146.865 327.825
202306 307.336 150.280 342.260
202309 337.140 151.492 372.448
202312 337.346 152.924 369.185
202403 330.254 153.035 361.163
202406 353.759 155.789 380.028
202409 388.653 157.882 411.978
202412 384.344 158.323 406.276
202503 302.862 157.552 321.711
202506 406.302 159.755 425.636
202509 438.419 162.289 452.110
202512 450.567 163.281 461.816
202603 458.754 164.272 467.369
202606 489.662 167.357 489.662

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹1,318.20 mean?
Apollo Hospitals Enterprise (BOM:508869) has a Cyclically Adjusted Revenue per Share of ₹1,318.20 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Apollo Hospitals Enterprise and its competitors.
Is Apollo Hospitals Enterprise's Cyclically Adjusted Revenue per Share too high?
Apollo Hospitals Enterprise's current Cyclically Adjusted Revenue per Share is ₹1,318.20. Overall, Apollo Hospitals Enterprise has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Apollo Hospitals Enterprise's Cyclically Adjusted Revenue per Share of ₹1,318.20 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Apollo Hospitals Enterprise and its competitors. Apollo Hospitals Enterprise's current Cyclically Adjusted Revenue per Share is ₹1,318.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹9,113.82, compared to a current price of ₹8,790.00 — trading 3.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹1,318.20. Apollo Hospitals Enterprise's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current Cyclically Adjusted Revenue per Share is ₹1,318.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?

Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be undervalued. The current stock price of ₹8,790.00 is trading 3.6% below its estimated GF Value™ of ₹9,113.82. GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.

Key valuation signals for BOM:508869:

  • Cyclically Adjusted Revenue per Share: ₹1,318.20
  • GF Value™: ₹9,113.82 vs. price of ₹8,790.00 (3.6% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Apollo Hospitals Enterprise Business Description

Other Exchanges APOLLOHOSP:India
Address No. 8-17, Shafee Mohammed Road, Sunny Side Building, East Block, 3rd Floor, Chennai, TN, IND, 600006
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
94GF Score

Get the complete analysis for BOM:508869

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,790.00
Price
₹9,113.82
GF Value